GOLDMAN SACHS GROUP INC - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 38 filers reported holding TENAX THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$54,000
-35.7%
26,266
+2.6%
0.00%
Q4 2015$84,000
+31.2%
25,611
+20.0%
0.00%
Q3 2015$64,000
-19.0%
21,337
-0.1%
0.00%
Q2 2015$79,000
+8.2%
21,360
-4.5%
0.00%
Q1 2015$73,000
-46.3%
22,366
-36.7%
0.00%
Q4 2014$136,000
-28.4%
35,347
-26.9%
0.00%
Q3 2014$190,00048,3530.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,163,363$300,0000.02%
Cardinal Capital Management 10,000$6,0000.00%
Verition Fund Management LLC 32,140$18,0000.00%
WFG Advisors, LP 15,000$8,0000.00%
BANK OF AMERICA CORP /DE/ 79$00.00%
WELLS FARGO & COMPANY/MN 26$00.00%
NORTHERN TRUST CORP 51,187$29,0000.00%
GROUP ONE TRADING, L.P. 17,153$10,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 91,755$51,0000.00%
MILLENNIUM MANAGEMENT LLC 161,784$91,0000.00%
View complete list of TENAX THERAPEUTICS INC shareholders